Opportunity Information: Apply for RFA AA 18 006

The Alcoholic Hepatitis Clinical and Translational Network Basic and Pre-Clinical Research (UH2/UH3) opportunity (RFA-AA-18-006) is a National Institutes of Health program run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to push alcoholic hepatitis (AH) research toward real-world clinical impact. The core purpose is to speed up the discovery and validation of better diagnostics and more effective treatments for patients with AH by continuing and strengthening a previously funded translational research effort. Instead of supporting isolated projects, NIAAA is organizing a coordinated Alcoholic Hepatitis Clinical and Translational Network (the "AH Network") designed to align basic science, pre-clinical development, and clinical needs so that promising findings can move more efficiently along the pipeline.

This specific funding announcement focuses on the network's basic and pre-clinical component. Applications are expected to propose high-impact laboratory and pre-clinical studies that directly support the broader network mission: generating mechanistic insight, identifying or validating therapeutic targets, developing and testing candidate interventions, and improving tools that could translate into clinical diagnostics or therapies. In practical terms, the basic and pre-clinical arm is meant to be the engine that produces well-supported candidates and biological rationale that the rest of the network can carry forward, rather than producing knowledge that remains disconnected from patient-facing progress.

The initiative is being implemented through a set of five related funding opportunity announcements that together build a consolidated AH Network with four major parts: (1) a clinical component, (2) a data coordinating center, (3) a translational component, and (4) the basic and pre-clinical component covered by this FOA. The network structure signals that awardees will not be working in a vacuum; the intention is for projects to integrate with shared goals, shared data practices, and coordinated decision-making across the network. The mechanism used is a Cooperative Agreement, which typically means NIH expects substantial programmatic involvement during the project, such as coordination, milestone tracking, and collaboration requirements that go beyond a standard investigator-initiated grant.

Funding is offered through the UH2/UH3 Phase Innovation Awards structure. This is a two-stage design commonly used to support milestone-driven work: an initial phase (UH2) that supports early-stage, feasibility, or development activities, followed by a second phase (UH3) that supports expanded implementation once defined milestones are met. In a network setting, this kind of staged award is often used to make sure projects can demonstrate readiness, reproducibility, and translational relevance before moving into more resource-intensive work, though the exact transition criteria are defined in the FOA and award terms.

Eligibility is broad and includes many common U.S. applicant types: state, county, city/township, and special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, the FOA draws a clear line on foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components may be allowed as defined under the NIH Grants Policy Statement, which generally means certain internationally based collaborations can be included under specific rules even though the applicant organization itself must be eligible and U.S.-based.

Administratively, this is a discretionary health-related funding opportunity (CFDA 93.273) under NIH. The original posting indicates an expected three awards, with an original closing date of October 23, 2017, and a creation date of August 23, 2017. While the notice does not list an award ceiling amount in the provided text, the intent is clearly to support a small number of coordinated projects that will meaningfully contribute to the network's overall translational agenda in alcoholic hepatitis.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Alcoholic Hepatitis Clinical and Translational Network Basic and Pre-Clinical Research (UH2/UH3)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
  • This funding opportunity was created on 2017-08-23.
  • Applicants must submit their applications by 2017-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AA 18 006

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

1) What is the name and identifier of this funding opportunity?

This opportunity is titled "The Alcoholic Hepatitis Clinical and Translational Network Basic and Pre-Clinical Research (UH2/UH3)" and is associated with RFA-AA-18-006.

2) Which NIH institute runs this program?

The program is run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), which is part of the National Institutes of Health (NIH).

3) What is the overall purpose of this initiative?

The core purpose is to push alcoholic hepatitis (AH) research toward real-world clinical impact by speeding the discovery and validation of improved diagnostics and more effective treatments for patients with AH, while continuing and strengthening a previously funded translational research effort.

4) What is the Alcoholic Hepatitis Clinical and Translational Network (AH Network)?

The AH Network is a coordinated NIH/NIAAA effort designed to align basic science, pre-clinical development, and clinical needs so that promising findings can move more efficiently along the pipeline toward patient-facing impact.

5) What part of the AH Network does this FOA support?

This specific funding announcement focuses on the network's basic and pre-clinical component.

6) What types of projects are expected under the basic and pre-clinical component?

Applications are expected to propose high-impact laboratory and pre-clinical studies that directly support the AH Network mission, such as work aimed at:

  • Generating mechanistic insight relevant to alcoholic hepatitis
  • Identifying or validating therapeutic targets
  • Developing and testing candidate interventions
  • Improving tools that could translate into clinical diagnostics or therapies

7) How is this program different from funding isolated, stand-alone projects?

The FOA emphasizes that awardees are not expected to work in a vacuum. The intention is to support work that functions as an engine for the broader network, producing well-supported candidates and biological rationale that can be carried forward, rather than generating knowledge disconnected from clinical progress.

8) How many related funding announcements make up the full network initiative?

The initiative is implemented through a set of five related funding opportunity announcements that together build the consolidated AH Network.

9) What are the major parts of the consolidated AH Network?

The network is described as having four major parts:

  1. A clinical component
  2. A data coordinating center
  3. A translational component
  4. The basic and pre-clinical component (covered by this FOA)

10) What funding mechanism is used for this opportunity?

The mechanism used is a Cooperative Agreement, which typically indicates substantial NIH programmatic involvement during the project, such as coordination, milestone tracking, and collaboration requirements beyond what is typical for a standard investigator-initiated grant.

11) What does the UH2/UH3 structure mean in this FOA?

Funding is offered through the UH2/UH3 Phase Innovation Awards structure, which is a two-stage, milestone-driven design:

  • UH2 phase: Supports early-stage feasibility and/or development activities.
  • UH3 phase: Supports expanded implementation once defined milestones are met.

12) How does the UH2 to UH3 transition work?

The opportunity describes a milestone-driven approach where the UH3 phase supports expanded implementation once defined milestones are met. The exact transition criteria are defined in the FOA and award terms.

13) Who is eligible to apply?

Eligibility is broad and includes many U.S. applicant types, including:

  • State, county, city/township, and special district governments
  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Independent school districts
  • Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments)
  • Public housing authorities/Indian housing authorities
  • Nonprofits with or without 501(c)(3) status (other than institutions of higher education)
  • For-profit organizations (other than small businesses)
  • Small businesses

14) Are specific institution types explicitly highlighted as eligible?

Yes. The FOA explicitly highlights additional eligible applicant categories such as:

  • Historically Black Colleges and Universities (HBCUs)
  • Hispanic-serving institutions
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
  • Faith-based or community-based organizations
  • Eligible federal agencies
  • Regional organizations
  • U.S. territories or possessions

15) Are foreign organizations eligible to apply?

No. The FOA states that non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply.

16) Are non-domestic components of U.S. organizations eligible to apply?

No. The FOA states that non-domestic components of U.S. organizations are not eligible to apply.

17) Can a U.S.-based applicant include a foreign component or international collaboration?

The FOA notes that foreign components may be allowed as defined under the NIH Grants Policy Statement, meaning certain internationally based collaborations can be included under specific rules even though the applicant organization must be eligible and U.S.-based.

18) What CFDA number is associated with this opportunity?

This discretionary health-related funding opportunity is associated with CFDA 93.273.

19) How many awards were expected under the original posting?

The original posting indicates an expectation of three awards.

20) What were the key dates listed for the opportunity?

The provided information lists:

  • Creation date: August 23, 2017
  • Original closing date: October 23, 2017

21) Is an award ceiling amount provided in the information shown?

No. The provided text does not list an award ceiling amount.

22) What does the FOA suggest about the scale or selectivity of awards?

While no ceiling is provided in the text, the intent is described as supporting a small number of coordinated projects that will meaningfully contribute to the network's overall translational agenda in alcoholic hepatitis.

23) What kind of collaboration expectations are implied for awardees?

The FOA signals integration with shared goals, shared data practices, and coordinated decision-making across the network, consistent with the Cooperative Agreement approach.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: FY 2018 Study of the U.S. Institutes for Secondary Educators

Previous opportunity: Notice of Intent

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AA 18 006

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AA 18 006) also looked into and applied for these:

Funding Opportunity
Research Centers in Minority Institutions (RCMI) (U54) Apply for RFA MD 17 006

Funding Number: RFA MD 17 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Coinfection Surveillance Strategies for Program Planning in Central America and Panama Region in Guatemala Apply for CDC RFA GH13 134405CONT18

Funding Number: CDC RFA GH13 134405CONT18
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Strengthening Clinical Services of PLHIV in Central America under PEPFAR Apply for CDC RFA GH17 177602CONT18

Funding Number: CDC RFA GH17 177602CONT18
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR Apply for CDC RFA GH15 151004CONT18

Funding Number: CDC RFA GH15 151004CONT18
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Establishment of a Strategic Partnership to Strengthen the COMISCA under PEPFAR Apply for CDC RFA GH15 150904CONT18

Funding Number: CDC RFA GH15 150904CONT18
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) Apply for PAR 17 466

Funding Number: PAR 17 466
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) Apply for PAR 17 463

Funding Number: PAR 17 463
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21) Apply for PAR 17 474

Funding Number: PAR 17 474
Agency: National Institutes of Health
Category: Health
Funding Amount: $125,000
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44) Apply for PAR 17 480

Funding Number: PAR 17 480
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44) Apply for PAR 17 479

Funding Number: PAR 17 479
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33) Apply for RFA AI 17 036

Funding Number: RFA AI 17 036
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional) Apply for RFA AI 17 028

Funding Number: RFA AI 17 028
Agency: National Institutes of Health
Category: Health
Funding Amount: $800,000
Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32) Apply for PA 17 481

Funding Number: PA 17 481
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Comparative Genomics Research Program (R01) Apply for PAR 17 482

Funding Number: PAR 17 482
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159403CONT18

Funding Number: CDC RFA GH15 159403CONT18
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25) Apply for PAR 17 485

Funding Number: PAR 17 485
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Accessible Continuum of Care and Essential Services Sustained (ACCESS) Apply for RFI 687 17 002

Funding Number: RFI 687 17 002
Agency: Madagascar USAID-Antananarivo
Category: Health
Funding Amount: $85,000,000
Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34) Apply for RFA RM 17 024

Funding Number: RFA RM 17 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01) Apply for RFA RM 17 023

Funding Number: RFA RM 17 023
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIH Science Education Partnership Award (SEPA) (R25) Apply for PAR 17 339

Funding Number: PAR 17 339
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 18 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: